CLINICAL RELEVANCE OF DOPAMINE RECEPTOR CLASSIFICATION

被引:15
|
作者
CALNE, DB
机构
关键词
D O I
10.1016/0165-6147(80)90067-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:412 / 414
页数:3
相关论文
共 50 条
  • [21] Bleeding classification in clinical trials: Observer variability and clinical relevance
    Graafsma, YP
    Prins, MH
    Lensing, AWA
    Huismar, MV
    Buller, HR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1181 - P1181
  • [22] Bleeding classification in clinical trials: Observer variability and clinical relevance
    Graafsma, YP
    Prins, MH
    Lensing, AWA
    deHaan, RJ
    Huisman, MV
    Buller, HR
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (04) : 1189 - 1192
  • [23] Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function
    Fuxe, Kjell
    Ferre, Sergi
    Genedani, Susanna
    Franco, Rafael
    Agnati, Luigi F.
    PHYSIOLOGY & BEHAVIOR, 2007, 92 (1-2) : 210 - 217
  • [24] DOPAMINE RECEPTOR CLASSIFICATION, NEUROANATOMICAL DISTRIBUTION AND INVIVO IMAGING
    BRUCKE, T
    WENGER, S
    PODREKA, I
    ASENBAUM, S
    WIENER KLINISCHE WOCHENSCHRIFT, 1991, 103 (21) : 639 - 646
  • [25] RELEVANCE OF DOPAMINE AUTORECEPTORS FOR PSYCHIATRY - PRE-CLINICAL AND CLINICAL-STUDIES
    MELTZER, HY
    SCHIZOPHRENIA BULLETIN, 1980, 6 (03) : 456 - 475
  • [27] The Relevance of the Dopamine-D1 Receptor in the Cognitive Symptoms of Schizophrenia
    Patricia S Goldman-Rakic
    Neuropsychopharmacology, 1999, 21 : S170 - S180
  • [28] The relevance of the dopamine-D1 receptor in the cognitive symptoms of schizophrenia
    Goldman-Rakic, PS
    NEUROPSYCHOPHARMACOLOGY, 1999, 21 (06) : S170 - S180
  • [29] Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
    Perreault, Melissa L.
    Hasbi, Ahmed
    O'Dowd, Brian F.
    George, Susan R.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (01) : 156 - 168
  • [30] Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
    Melissa L Perreault
    Ahmed Hasbi
    Brian F O'Dowd
    Susan R George
    Neuropsychopharmacology, 2014, 39 : 156 - 168